Showing results (501-510 of 604) with videos related to

Sort By:
Pageof 61
BJOG : an International Journal of Obstetrics and Gynaecology|December 20, 2024
Safety of Fertility Treatments in Women With Systemic Lupus Erythematosus: Data From a Prospective Population-Based StudyAmandine Dernoncourt, Gaëlle Guettrot-Imbert, Loïc Sentilhes, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitisSophie Nagle, Yann Nguyen, Mary-Jane Guerry, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Arthritis Research & Therapy|February 22, 2012
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen, Alan Tyndall, Eric Hachulla, et al.
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Rheumatology (Oxford, England)|October 3, 2022
Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 casesYann Nguyen, Cécile M Yelnik, Nathalie Morel, et al.
Pageof 61